ERA

Download the full-sized PDF of Omics-based bioactive and drug discovery in Bacillus spp.Download the full-sized PDF

Analytics

Share

Permanent link (DOI): https://doi.org/10.7939/R3J960N4N

Download

Export to: EndNote  |  Zotero  |  Mendeley

Communities

This file is in the following communities:

Biological Sciences, Department of

Collections

This file is in the following collections:

R.E. Peter Biology Conference

Omics-based bioactive and drug discovery in Bacillus spp. Open Access

Descriptions

Author or creator
Albert Remus Rosana
Additional contributors
Mohamed Seghir Daas
Jeella Acedo
Subject/Keyword
Genomics, Proteomics, Targeted Metabolomics, Bioactives,
Type of item
Conference/workshop Poster
Language
English
Place
Time
Description
Several strains of Bacillus spp. were isolated from across Algeria, the largest African country. The strains were bioprospected from several economically-relevant environments such as oil-mining sites, salty lakes, coal mines, deserts and oil-contaminated water basins. Hundreds of isolates were extensively screened for extracellular enzyme and lipid-emulsifying properties and pathogen-inhibition activities. Potent strains were further subjected to both genomics and proteomics-metabolomics based-pipelines for gene-cluster and bioactive peptide discovery, respectively. Whole genome shotgun sequencing revealed new strains of Bacillus spp. namely: the insecticidal B. thuringensis; the biosurfactant-producing B. amyloliquefaciens; the bacteriocin-producing B. paralicheniformis; the food borne-pathogen B. cereus and the soil-borne pathogen B. anthacis. Cluster gene analyses revealed an extensive repertoire of secondary metabolite families encoded in the genome of these new Bacillus strains such as bacteriocins, terpenes, lassopeptides, lipopeptides, homoserine lactones, and siderophores. These bioinformatically predicted gene inventories were coupled with metabolomics platforms to confirm a number of biotechnologically relevant molecules. Nuclear magnetic resonance spectroscopy (NMR) and liquid chromatography-mass spectrometry (LC-MS) identified several potent bioactives such as fengycins, lantipeptides and microcins with strong bactericidal activity against common food borne-pathogens such as E. coli, Salmonella and S. aureus. Here, we will present the direct biotechnological application of genomics and targeted metabolomics in microbial bioactive predictions and drug discovery.
Date created
2017/1/30
DOI
doi:10.7939/R3J960N4N
License information
Public Domain Mark 1.0
Rights

Citation for previous publication
Project presented (poster and 3MT) at the RE Peter Biology Conference 2017, Dept of Biological Sciences, University of Alberta, Jan 30-31, 2017 and 24th Metagenomics and Genomics Workshop, Joint Genome Institute-DOE, Walnut Creek, California, Feb 27-Mar3, 2017
Source

Link to related item

File Details

Date Uploaded
Date Modified
2017-02-18T11:43:14.464+00:00
Audit Status
Audits have not yet been run on this file.
Characterization
File format: pdf (Portable Document Format)
Mime type: application/pdf
File size: 2598303
Last modified: 2017:02:18 10:32:04-07:00
Filename: JGI-DOE 24th MGM_Bacillus Omics.pdf
Original checksum: 89742244d389894589183b3506509a27
Well formed: true
Valid: true
File title: PowerPoint Presentation
File author: Albert Rosana
Page count: 1
File language: en-US
Activity of users you follow
User Activity Date